Vasoactive Intestinal Peptide (VIP) | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Vasoactive Intestinal Peptide (VIP)

Also known as: VIP, Vasoactive Intestinal Polypeptide, Vasoactive Intestinal Peptide

Neuropeptide / Neuroendocrine peptide (secretin/glucagon family)

Research chemicalLast updated: October 19, 2026Based on 27 peer-reviewed studies

What it is

VIP is a natural peptide that regulates blood vessel dilation, immune function, and airway relaxation; researchers are studying it for asthma, allergic diseases, circadian rhythm disorders, and autoimmune conditions. It works by binding receptors in both the nervous and immune systems to reduce inflammation and relax smooth muscle. No FDA-approved therapeutic use in this form.

The scientific side

VIP is a 28-amino acid neuropeptide member of the secretin/glucagon family, originally isolated from porcine duodenum and later found throughout the central and peripheral nervous systems and in endocrine cells. VIP mediates its biological effects by binding to specific receptors — principally VPAC1 and VPAC2 (also designated VIP-1 and VIP-2 receptors), as well as PAC1 and CRTH2 — which are expressed on a wide variety of cell types including immune cells (eosinophils, mast cells, neutrophils, lymphocytes), smooth muscle, cardiac tissue, and neurons. Receptor binding activates adenylyl cyclase, increasing intracellular cAMP, which in turn drives downstream signaling cascades. VIP also modulates nitric oxide and cyclic GMP signaling in vascular tissues. Its actions include vasodilation, smooth muscle relaxation, anti-inflammatory and immunomodulatory effects, regulation of gastric motility, hormonal secretion, neurotrophic and neuroprotective functions, and modulation of circadian rhythms in the suprachiasmatic nucleus (SCN).

Class: Neuropeptide / Neuroendocrine peptide (secretin/glucagon family)

Administration & storage

Administration
Intrathecal injection (animal studiesrats) (PMID: 12860207)Intraperitoneal injection (i.p.) (animal studiesmice) (PMID: 25086267)Intracoronary or intravenous administration (human and animal cardiovascular studies) (PMID: 11121793)Intravenous infusion for 20 minutes (human cluster headache provocation study) (PMID: 37143998)Intravesical infusion of saline (cystometryVIP knockout mice) (PMID: 18561033)Intravenous injection of MNU 50 mg/kg to induce breast cancer model (ratnot VIP administration) (PMID: 11245339)
Storage
No storage conditions for VIP are described in the reviewed abstracts.
Cautions
VIP is reported to be rapidly degraded in vivo; metabolic instability is a recognized limitation of native VIP, and VIP-based drugs are described as not yet in clinical use partly because of poor metabolic stability and poor penetration to desired sites of action.,Tyrosine residues (Tyr10 and Tyr22) of VIP can be nitrated under inflammatory/oxidative conditions (heme or Cu2+ with H2O2 and NO2-), which dramatically decreases alpha-helix content and reduces cAMP secretion, indicating that the peptide may lose biological activity in inflammatory environments.,Intrathecal VIP produced early antinociception followed by hyperalgesia in a concentration-dependent manner in rats; the dual and opposing effects of VIP on nociception indicate complex, dose-dependent pharmacology.,Long-term i.p. administration of native VIP (not VIP-TAT) aggravated scopolamine-induced amnesia in mice, suggesting VIP may exert opposite effects in brain versus peripheral compartments depending on delivery method.,No human safety, tolerability, or pharmacokinetic data for exogenously administered VIP are described in the reviewed abstracts. Use of any research-grade peptide outside of a supervised clinical setting carries inherent risks. Sterile technique is essential for any injectable preparation.

Legal & regulatory status

US FDA

Not stated in reviewed literature — requires manual verification

WADA

Not stated in reviewed literature — requires manual verification

Health Canada

Not stated in reviewed literature — requires manual verification